0460

COM:SIHUANPHARM

四环医药

  • Stock

Last Close

0.70

22/11 08:08

Market Cap

5.20B

Beta: -

Volume Today

17.55M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
96.38M
-
139.23M
44.47%
205.10M
47.31%
216.85M
5.73%
214.32M
1.17%
264.54M
23.43%
355.36M
34.33%
452.74M
27.41%
605.59M
33.76%
661.00M
9.15%
582.01M
11.95%
average payables
36.38M
-
38.69M
6.34%
56.72M
46.62%
77.64M
36.89%
58.49M
24.67%
35.76M
38.86%
51.46M
43.90%
85.96M
67.04%
112.55M
30.94%
162.34M
44.24%
213.20M
31.32%
average receivables
-64.72M
-
460.03M
-
book value per share
0.76
-
0.90
17.73%
1.07
19.41%
1.08
0.42%
1.17
8.46%
1.32
13.28%
1.01
23.19%
0.97
4.31%
0.88
9.53%
0.51
42.20%
0.48
6.11%
capex per share
-0.11
-
-0.07
35.65%
-0.06
20.99%
-0.04
37.37%
-0.05
42.85%
-0.04
19.94%
-0.07
65.81%
-0.06
10.04%
-0.08
32.66%
-0.06
21.77%
capex to depreciation
-5.97
-
-3.60
39.74%
-2.27
36.99%
-1.25
44.69%
-1.64
30.87%
-1.27
22.69%
-1.82
43.58%
-2.09
14.64%
-2.48
18.89%
-1.61
35.26%
capex to operating cash flow
-0.77
-
-0.43
44.73%
-0.38
11.30%
-0.18
52.36%
-0.25
40.58%
-0.22
14.47%
-0.46
109.59%
-2.56
461.44%
-1.15
54.88%
-12.77
1,007.46%
capex to revenue
-0.25
-
-0.24
1.13%
-0.19
23.05%
-0.11
39.07%
-0.18
54.98%
-0.13
24.74%
-0.22
67.51%
-0.24
5.37%
-0.23
1.04%
-0.27
16.78%
cash per share
0.24
-
0.28
16.44%
0.41
44.48%
0.41
0.80%
0.40
1.32%
0.49
21.70%
0.56
14.05%
0.52
6.22%
0.61
17.75%
0.51
16.37%
0.47
8.53%
days of inventory on hand
35.79
-
66.48
85.76%
90.57
36.23%
73.49
18.86%
109.64
49.19%
204.17
86.22%
252.52
23.68%
329.22
30.38%
309.80
5.90%
319.27
3.06%
360.11
12.79%
days payables outstanding
12.92
-
15.31
18.57%
28.23
84.30%
30.27
7.24%
16.51
45.47%
25.22
52.83%
40.52
60.62%
70.51
74.02%
51.50
26.96%
108.29
110.28%
142.55
31.63%
days sales outstanding
78.04
-
debt to assets
0.02
-
0.00
98.34%
0.00
117.41%
-0.00
741.65%
0.01
-
0.00
75.50%
0.06
3,740.12%
0.07
28.88%
0.11
42.53%
0.11
0.01%
debt to equity
0.02
-
0.00
98.41%
0.00
98.11%
-0.00
746.00%
0.01
-
0.00
74.02%
0.08
4,064.96%
0.13
58.89%
0.27
108.76%
0.28
1.56%
dividend yield
0.02
-
0.01
69.13%
0.01
31.35%
0.03
317.40%
0.05
67.41%
0.02
59.01%
0.03
19.16%
0.22
764.20%
0.05
75.58%
0.17
211.52%
earnings yield
0.05
-
0.04
15.04%
0.05
41.08%
0.09
59.37%
0.07
24.66%
0.14
118.48%
-0.35
344.86%
0.07
120.42%
0.02
71.50%
-0.29
1,536.06%
-0.01
96.64%
enterprise value
27.25B
-
41.83B
53.47%
35.46B
15.22%
17.21B
51.46%
21.25B
23.43%
8.08B
61.98%
2.76B
65.89%
2.75B
0.07%
6.79B
146.63%
5.37B
20.97%
2.92B
45.52%
enterprise value over ebitda
15.47
-
18.62
20.36%
14.41
22.58%
7.21
49.99%
11.39
58.03%
3.73
67.27%
-2.83
175.83%
3.11
210.07%
6.97
123.84%
-44.32
736.18%
17.20
138.82%
ev to operating cash flow
18.04
-
23.75
31.65%
22.61
4.82%
8.53
62.27%
11.08
29.90%
4.51
59.33%
1.94
56.87%
12.12
523.79%
10.21
15.80%
115.44
1,030.92%
ev to sales
5.76
-
13.56
135.49%
11.20
17.44%
5.40
51.74%
7.74
43.21%
2.77
64.21%
0.95
65.53%
1.12
17.07%
2.06
84.66%
2.46
19.26%
1.57
36.14%
free cash flow per share
0.03
-
0.10
194.32%
0.09
3.41%
0.16
73.56%
0.15
7.48%
0.15
1.78%
0.08
44.95%
-0.04
145.78%
-0.01
71.00%
-0.06
441.81%
free cash flow yield
0.01
-
0.02
95.20%
0.03
10.43%
0.08
226.73%
0.06
23.15%
0.12
91.70%
0.10
20.83%
-0.05
154.44%
-0.01
83.25%
-0.07
672.42%
graham net net
0.05
-
0.11
99.39%
0.31
191.60%
0.30
5.01%
0.17
40.94%
0.22
26.83%
0.30
35.36%
0.22
26.44%
0.09
61.39%
-0.15
276.75%
-0.16
3.79%
graham number
1.47
-
1.80
22.80%
2.19
21.38%
2.02
7.80%
2.00
0.81%
2.25
12.61%
2.58
14.36%
1.05
59.46%
0.70
33.18%
1.69
141.30%
0.25
85.19%
income quality
0.96
-
0.85
11.88%
0.55
35.01%
0.94
69.84%
1.11
18.30%
0.89
19.66%
-0.57
164.51%
0.31
154.07%
1.37
340.48%
-0.02
101.63%
intangibles to total assets
0.29
-
0.25
13.57%
0.23
8.06%
0.23
1.44%
0.31
32.66%
0.27
13.79%
0.11
59.09%
0.04
63.41%
0.04
8.46%
0.05
20.17%
0.06
10.11%
interest coverage
181.44
-
340.22
87.51%
16.84K
4,849.65%
10.15K
39.74%
36.70K
261.65%
334.31
99.09%
267.39
20.02%
73.80
72.40%
6.40
91.32%
-2.62
140.99%
interest debt per share
0.02
-
0.00
95.22%
0.00
9.42%
-0.01
733.85%
0.00
100.09%
0.01
219,863.97%
0.00
76.42%
0.08
3,105.14%
0.13
57.89%
0.16
26.46%
0.13
18.04%
inventory turnover
10.20
-
5.49
46.17%
4.03
26.60%
4.97
23.24%
3.33
32.97%
1.79
46.30%
1.45
19.15%
1.11
23.30%
1.18
6.27%
1.14
2.97%
1.01
11.34%
invested capital
0.02
-
0.00
98.41%
0.00
98.11%
-0.00
746.00%
0.01
-
0.00
74.02%
0.08
4,064.96%
0.13
58.89%
0.27
108.76%
0.28
1.56%
market cap
28.58B
-
43.14B
50.97%
37.74B
12.53%
19.61B
48.03%
22.08B
12.58%
11.30B
48.83%
7.85B
30.49%
6.60B
15.93%
11.39B
72.54%
7.91B
30.61%
5.48B
30.73%
net current asset value
3.15B
-
3.71B
17.80%
4.32B
16.39%
3.98B
7.86%
2.52B
36.70%
3.11B
23.38%
3.68B
18.30%
3.31B
9.98%
2.40B
27.59%
49.66M
97.93%
-194.65M
491.96%
net debt to ebitda
-0.75
-
-0.59
21.99%
-0.92
57.98%
-1.00
8.68%
-0.45
55.60%
-1.49
233.24%
5.23
451.99%
-4.35
183.16%
-4.72
8.49%
20.96
544.02%
-15.02
171.65%
net income per share
0.13
-
0.16
28.10%
0.20
23.39%
0.17
15.35%
0.15
9.29%
0.17
11.94%
-0.29
270.26%
0.05
117.17%
0.02
50.65%
-0.25
1,107.33%
-0.01
97.66%
operating cash flow per share
0.15
-
0.17
16.42%
0.15
10.93%
0.20
31.49%
0.20
1.62%
0.19
6.39%
0.15
20.89%
0.02
83.98%
0.07
193.98%
0.00
92.94%
payables turnover
28.26
-
23.83
15.66%
12.93
45.74%
12.06
6.76%
22.11
83.40%
14.47
34.57%
9.01
37.74%
5.18
42.54%
7.09
36.91%
3.37
52.44%
2.56
24.03%
receivables turnover
4.68
-
research and ddevelopement to revenue
0.16
-
0.22
33.17%
0.30
34.96%
0.26
10.86%
0.43
62.80%
0.31
27.69%
return on tangible assets
0.18
-
0.20
7.51%
0.22
10.46%
0.18
15.91%
0.15
15.62%
0.14
7.29%
-0.25
272.34%
0.04
115.36%
0.02
55.60%
-0.20
1,300.72%
-0.00
97.54%
revenue per share
0.46
-
0.30
34.92%
0.31
2.68%
0.31
2.80%
0.29
7.83%
0.31
6.38%
0.30
1.01%
0.26
14.62%
0.35
34.05%
0.23
33.01%
0.20
14.40%
roe
0.17
-
0.18
8.81%
0.19
3.34%
0.16
15.70%
0.13
16.37%
0.13
1.19%
-0.29
321.66%
0.05
117.95%
0.03
45.45%
-0.49
1,842.71%
-0.01
97.51%
roic
0.15
-
0.17
14.24%
0.17
0.92%
0.15
12.20%
0.13
14.81%
0.13
2.71%
0.15
12.61%
0.04
71.19%
0.04
10.59%
-0.10
355.68%
-0.04
61.16%
sales general and administrative to revenue
0.07
-
0.16
125.43%
0.14
7.55%
0.17
17.87%
0.23
35.03%
0.14
40.73%
0.17
23.67%
0.20
18.37%
0.18
7.14%
0.25
37.16%
0.25
0.44%
shareholders equity per share
0.76
-
0.90
17.73%
1.07
19.41%
1.08
0.42%
1.17
8.46%
1.32
13.28%
1.01
23.19%
0.97
4.31%
0.88
9.53%
0.51
42.20%
0.48
6.11%
stock based compensation to revenue
0.00
-
0.01
161.52%
0.00
54.12%
-0.00
103.50%
0.00
539.10%
0.00
81.71%
0.00
3.40%
0.01
7,591.78%
0.02
91.73%
0.04
127.97%
0.05
16.47%
tangible asset value
5.12B
-
6.59B
28.79%
8.37B
27.08%
8.14B
2.75%
7.15B
12.16%
8.68B
21.30%
8.58B
1.16%
9.43B
9.94%
8.53B
9.60%
5.01B
41.22%
4.48B
10.61%
tangible book value per share
0.49
-
0.64
28.62%
0.81
27.07%
0.80
0.61%
0.75
6.06%
0.92
21.45%
0.91
1.12%
1.00
9.97%
0.90
9.27%
0.54
40.58%
0.48
10.30%
working capital
3.36B
-
3.93B
17.10%
4.51B
14.74%
4.16B
7.90%
2.87B
30.93%
3.53B
22.88%
4.04B
14.64%
3.96B
2.06%
5.24B
32.28%
4.02B
23.33%
2.10B
47.80%

All numbers in (except ratios and percentages)